Sep 2026· Proteomics· pp.
e70179
· 0 citations· 39 references
Medicine
Abstract
Chemoproteomics aims to achieve precise and comprehensive quantification of protein-small molecule interactions, yet methodological comparisons across quantitative proteomics workflows remain scarce. Here, we systematically benchmark tandem mass tag data-dependent acquisition (TMT-DDA) on Orbitrap Exploris/Eclipse instruments against label-free data-independent acquisition parallel accumulation-serial fragmentation (LFQ-diaPASEF) on a timsTOF Pro 2 mass spectrometer when applied for 2-dimensional thermal proteome profiling (2D-TPP) and Kinobeads-based chemoproteomics. Our findings demonstrate that TMT-DDA provided more confident detection of compound-induced thermal shifts despite having lower proteome coverage in high-complexity 2D-TPP datasets. In contrast, LFQ-diaPASEF excelled in low-complexity affinity enrichment experiments, achieving up to 63% broader total proteome coverage and comparable quantitative accuracy, even with ultra-short gradients. Additionally, we show that normalization strategies in DIA require careful selection to avoid artifacts when transforming IC50s into apparent dissociation constants (Kd apps). These findings emphasize that the trade-offs inherent to each platform critically impact chemoproteomics experiments and that instrument-method pairings should be selected based on experimental complexity, quantitative precision, data completeness needs, and throughput demands.
Recent instrumental and computational innovations in mass-spectrometry-based proteomics offer new promise in biomarker discovery, thanks to unprecedented proteome coverage and depth. Data-independent acquisition (DIA) methods are very promising in this context as they allow improved proteome coverage, reduced missing v...
J. Rijal, Imane Charmarke Askar, Aurélie Hirschler et al.· Analytical Chemistry· 0 citations
Proteomics has evolved from a predominantly mass spectrometry (MS)-based discipline into a broader analytical field that includes complementary affinity-based technologies for large-scale protein characterization. MS remains the cornerstone of modern proteomics because it enables unbiased identification and quantificat...
Dimitra Papatziamou, A. Singh, Mehul V. Makwan et al.· Biochimica et Biophysica Act...· 0 citations
Improvements enabling quantification of site-specific modifications, including post-translational modifications and covalent compound-protein interactions spanning diverse pathways are described.
Steven R. Shuken, Geordon A. Frere, Charlotte R. Beard et al.· Nature Communications· 0 citations
This first study to include Olink Reveal in a systematic cross-platform comparison and to directly compare the Orbitrap Astral with the previous-generation Orbitrap Exploris 480 under identical conditions provides a concrete, evidence-based framework for workflow selection and support the co-deployment of deep MS and h...
Jean-Marc Monneuse, Hayat Hage, Célie Da Silva et al.· Journal of Proteomics· 0 citations
The discovery of alternative proteins (AltProts), translated from non-canonical ORFs, has expanded the human proteome and revealed a hidden layer known as the “ghost proteome”. Despite increasing evidence, AltProts detection remains challenging due to their small size, physicochemical heterogeneity, and lack of annotat...
A. Montero-Calle, A. Peláez-García, A. J. Martín-Galiano et al.· bioRxiv· 0 citations
Summary Characterizing proteome complexity in disease contexts is essential for understanding molecular mechanisms and advancing therapeutic development. Mass spectrometry (MS)-based top-down and middle-down proteomics (TDP/MDP) can resolve intact proteoforms — protein molecules carrying a unique combination of isoform...
Araf Mahmud, Zhi-Hao Zhang, Si Wu et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.